Women who are pregnant, lactating or of childbearing potential are commonly excluded from cardiovascular randomized controlled trials — this needs to change.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Regitz-Zagrosek, V. et al. Eur. Heart J. 39, 3165–3241 (2018).
Pieper, P. G. Nat. Rev. Cardiol. 12, 718–729 (2015).
Pacheco, C. et al. CJC Open 4, 243–262 (2022).
Van Spall, H. G. C., Toren, A., Kiss, A. & Fowler, R. A. J. Am. Med. Assoc. 297, 1233–1240 (2007).
Collier, A. Y. & Molina, R. L. Neoreviews 20, e561–e574 (2019).
Van Spall, H. G. C. Eur. Heart J. 42, 2724–2726 (2021).
Filbey, L., Khan, M. S. & Van Spall, H. G. C. Am. Heart J. Plus 13, 100091 (2022).
Whitelaw, S. et al. Eur. J. Heart Fail. 23, 15–24 (2021).
Michos, E. D. & Van Spall, H. G. C. Nat. Rev. Cardiol. 18, 537–538 (2021).
Zhu, J. W., Reed, J. L. & Van Spall, H. G. C. Eur. Heart J. 43, 1609–1611 (2022).
Khan, S. U. et al. JAMA Netw. Open 3, e205202 (2020).
Filbey, L. et al. Eur. Heart J. 44, 921–930 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
H.G.C.V. serves on several international committees that aim to enhance representativeness in clinical trials, leads clinical trials funded by the Canadian Institutes of Health Research, and has no related financial or other competing interests. E.A. declares no competing interests.
Rights and permissions
About this article
Cite this article
Assadpour, E., Van Spall, H.G.C. Pregnant and lactating women should be included in clinical trials for cardiovascular disease. Nat Med 29, 1897–1899 (2023). https://doi.org/10.1038/s41591-023-02416-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02416-2
This article is cited by
-
Femtechs take on women’s health
Nature Biotechnology (2024)
-
A life-course approach to women’s health
Nature Medicine (2024)
-
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity
Current Atherosclerosis Reports (2023)